Skip to main content
OpenTrials
Completed

NCT Number: NCT02933424

Project Plant Protein: the P3 Study in Humans

The objective of this study is to compare the effects of adding three plant-based proteins (rice, oats and pea proteins) to a breakfast beverage on the glycemic response, appetite and subsequent food intake of healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Nutrition Research Centre

Singapore

About this study

A diet or a meal higher in dietary protein has been reported to promote satiety and suppress food intake in humans in several previous studies. It was suggested that the presence of amino acid in the blood as a result of higher protein intake served as signals that suppress appetite in humans. More recently, it has been observed that incomplete or lower quality proteins, i.e. those missing one or more essential amino acids, may suppress hunger more than complete proteins, as the ingestion of incomplete proteins in the long term may lead to deficiency of essential amino acids. Plant proteins are generally considered incomplete protein when compared to animal proteins, which mean that plant protein may have higher appetite-suppressing effects.

Dietary carbohydrates are the most potent stimuli of insulin secretion. However, the addition of dietary protein in a carbohydrate-rich meal has been shown to further stimulate insulin release.The insulinotropic effect of dietary protein is thought to be attributed to the branched-chain amino acid (BCAA) content of the protein-rich meal. Interestingly, there is a hierarchy of effects induced by protein from different sources. For example, milk protein has been shown to be superior to fish or plant protein in stimulating insulin secretion following a meal.Even within milk protein, whey protein stimulated insulin secretion more than casein protein. One of the factors that distinguish whey from casein proteins was the digestibility or the digestion rate of these proteins. Protein that is digested faster appear to increase blood amino acid levels faster, and increase insulin release faster.This implies that plant proteins that have lower digestibility rate relative to animal proteins may have lower insulinotropic effects, and the effective dose required to achieve optimal insulin secretion may be different from animal protein and warrants further investigation. In addition, the amino acid profile (in addition to lower digestibility) of plant proteins may differ from animal protein, especially the BCAA content that is associated with the stimulation of insulin secretion.

Dietary patterns and cuisines vary between countries and cultures. Unlike in the Western countries, plant-based foods are more commonly consumed in an Asian cuisine. Based on the statistics released by Food and Agriculture Organization, cereals and meat are the top two protein sources in both Western (29.1% and 26.4% respectively) and Asian (58.8% and 8.6% respectively) countries. The third major source of protein is dairy (16.7%) in Western countries, and pulses in Asia (7.4%). In addition, vegetarianism is widely practiced in Asian countries. Studies investigating the appetitive and the blood glucose regulating effects of dietary protein have been focused predominantly in animal protein, with a number of studies included plant-based protein such as soy protein. Since cereals and pulses are an important part of an Asian cuisine, it is important to understand and compare the effects of proteins from these sources on blood glucose and appetite regulation. Since the amino acid profile and the digestibility of these plant-based proteins differ from animal protein, it is important to also understand the effective dose that exerts optimal effects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males
  • BMI 18.5-24.9kgm-2
  • eating all meals (5 days/week)

Exclusion criteria

  • major chronic disease such as heart disease, cancer, hypertension or diabetes mellitus
  • have gout
  • have food allergies
  • are taking insulin or drugs known to affect metabolism, appetite and body fat distribution,
  • have weight change of >5kg in the past 3 months
  • have major medical or surgical event requiring hospitalisation within the preceding three months
  • are on a weight loss regime, and presence of disease or drugs which influence digestion and absorption of nutrients
  • smokers,
  • individuals who take part in sports at competitive/endurance levels

Treatment and study plan

Protein Powder

Dietary Supplement

Primary outcomes

  1. Change in blood glucose

    Time frame: Up to 180 minutes

    Blood glucose measured up to 180 minutes

  2. Change in blood insulin

    Time frame: Up to 180 minutes

    Blood insulin measured up to 180 minutes

  3. Change in gut hormones

    Time frame: Up to 180 minutes

    Blood gut hormones measured up to 180 minutes

  4. Change in body weight

    Time frame: At baseline

    Body weight measured with a Bio-electrical impedance scale

  5. Change in body composition

    Time frame: At baseline

    Fat% measured with a Bio-electrical impedance scale

Secondary outcomes

  1. Change in subjective appetite ratings

    Time frame: Up to 180 minutes

    Appetite ratings measured up to 180 minutes

  2. Change in plasma amino acid

    Time frame: Up to 180 minutes

    Blood amino acid profile measured up to 180 minutes

  3. Meal challenge

    Time frame: At 180 minutes

    Ad libitum meal challenge at 180-minutes

Sponsors and collaborators

Lead sponsor

Singapore Institute of Food and Biotechnology Innovation

Other Gov

Registry information

Official study title

The Effects of Plant Proteins on Blood Glucose & Amino Acid Levels and Satiety in Humans

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Oct 14, 2016
Registry last updated
Jan 25, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.